Daiwa Securities Group Inc. Adverum Biotechnologies, Inc. Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$9.84 - $14.26 $2,528 - $3,664	-257 Reduced 58.41%	183 $2,000
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $598 - $1,224	75 Added 20.55%	440 $4,000
Q4 2019 Jan 31, 2020	SELL	$5.12 - $12.22 $235 - $562	-46 Reduced 11.19%	365 $4,000
Q1 2019 Apr 26, 2019	BUY	$3.03 - $6.02 $1,245 - $2,474	411 New	411 $2,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.